These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33597299)

  • 1. Early systemic immune biomarkers predict bone regeneration after trauma.
    Cheng A; Vantucci CE; Krishnan L; Ruehle MA; Kotanchek T; Wood LB; Roy K; Guldberg RE
    Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33597299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.
    Vantucci CE; Guyer T; Leguineche K; Chatterjee P; Lin A; Nash KE; Hastings MA; Fulton T; Smith CT; Maniar D; Frey Rubio DA; Peterson K; Harrer JA; Willett NJ; Roy K; Guldberg RE
    Front Surg; 2022; 9():934773. PubMed ID: 35874126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired bone healing following treatment of established nonunion correlates with serum cytokine expression.
    Cheng A; Krishnan L; Pradhan P; Weinstock LD; Wood LB; Roy K; Guldberg RE
    J Orthop Res; 2019 Feb; 37(2):299-307. PubMed ID: 30480339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of systemic immune dysregulation in a rat trauma model of biomaterial-associated infection.
    Vantucci CE; Ahn H; Fulton T; Schenker ML; Pradhan P; Wood LB; Guldberg RE; Roy K; Willett NJ
    Biomaterials; 2021 Jan; 264():120405. PubMed ID: 33069135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
    Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
    mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Shifts in the immune processes and regeneration during the electrostimulation of the healing of mandibular fractures].
    Dmitrieva VS; Rivani AM
    Stomatologiia (Mosk); 1986; 65(2):38-41. PubMed ID: 3487143
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional block of IL-17 cytokine promotes bone healing by augmenting FOXO1 and ATF4 activity in cortical bone defect model.
    Dixit M; Singh KB; Prakash R; Singh D
    Osteoporos Int; 2017 Jul; 28(7):2207-2220. PubMed ID: 28341898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of matrix metalloproteases as early biomarkers for bone regeneration during the applied Masquelet therapy for non-unions.
    Haubruck P; Heller R; Apitz P; Kammerer A; Alamouti A; Daniel V; Schmidmaier G; Moghaddam A
    Injury; 2018 Oct; 49(10):1732-1738. PubMed ID: 30072031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Bone Regeneration with a Simple Blood Test.
    Mabilleau G; Delneste Y; Papon N
    Trends Mol Med; 2021 Jul; 27(7):622-623. PubMed ID: 33811008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cell cytokine secretion as prognostic factor in myelodysplastic syndromes.
    Han D; Tao J; Fu R; Shao Z
    Innate Immun; 2020 Nov; 26(8):703-715. PubMed ID: 33050756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5aR inhibition in the early inflammatory phase does not affect bone regeneration in a model of uneventful fracture healing.
    Ehrnthaller C; Huber-Lang M; Kovtun A; Rapp AE; Kemmler J; Gebhard F; Ignatius A
    Eur J Med Res; 2016 Oct; 21(1):42. PubMed ID: 27784330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of a genetically modified muscle flap for local BMP-2 production and its effects on bone healing: a histomorphometric and radiological study in a rat model.
    Lampert FM; Momeni A; Filev F; Torio-Padron N; Finkenzeller G; Stark GB; Steiner D; Koulaxouzidis G
    J Orthop Surg Res; 2015 Apr; 10():55. PubMed ID: 25924919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of TGF-ß1, PDGF and IGF-1 cytokine expression after fracture treatment vs. non-union therapy via masquelet.
    Fischer C; Doll J; Tanner M; Bruckner T; Zimmermann G; Helbig L; Biglari B; Schmidmaier G; Moghaddam A
    Injury; 2016 Feb; 47(2):342-9. PubMed ID: 26775211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine myeloid-derived suppressor cells are a source of elevated levels of interleukin-27 in early life and compromise control of bacterial infection.
    Gleave Parson M; Grimmett J; Vance JK; Witt MR; Seman BG; Rawson TW; Lyda L; Labuda C; Jung JY; Bradford SD; Robinson CM
    Immunol Cell Biol; 2019 May; 97(5):445-456. PubMed ID: 30575117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutualistic Effects of the Myeloid-Derived Suppressor Cells and Cancer Stem Cells in the Tumor Microenvironment.
    Tanriover G; Aytac G
    Crit Rev Oncog; 2019; 24(1):61-67. PubMed ID: 31679221
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Woolsey C; Borisevich V; Agans KN; Fenton KA; Cross RW; Geisbert TW
    mBio; 2021 Aug; 12(4):e0151721. PubMed ID: 34372693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.
    Yin J; Wang C; Huang M; Mao X; Zhou J; Zhang Y
    Cancer Med; 2016 Jul; 5(7):1654-69. PubMed ID: 27109254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.
    Lee CR; Lee W; Cho SK; Park SG
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
    Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
    Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compromised bone healing following spacer removal in a rat femoral defect model.
    Skaliczki G; Weszl M; Schandl K; Major T; Kovács M; Skaliczki J; Redl H; Szendrői M; Szigeti K; Máté D; Dobó-Nagy C; Lacza Z
    Acta Physiol Hung; 2012 Jun; 99(2):223-32. PubMed ID: 22849847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.